Impact analysis of heart failure across European countries: an ESC-HFA position paper
Giuseppe M C Rosano 1, Petar Seferovic 2, Gianluigi Savarese 3, Ilaria Spoletini 1, Yuri Lopatin 4, Fin Gustafsson 5 6, Antoni Bayes-Genis 7, Tiny Jaarsma 8, Magdy Abdelhamid 9, Arantxa Gonzalez Miqueo 10, Massimo Piepoli 11, Carlo G Tocchetti 12, Arsen D Ristić 2 13, Ewa Jankowska 14, Brenda Moura 15, Loreena Hill 16, Gerasimos Filippatos 17, Marco Metra 18, Davor Milicic 19, Thomas Thum 20, Ovidiu Chioncel 21, Tuvia Ben Gal 22, Lars H Lund 3, Dimitrios Farmakis 23, Wilfried Mullens 24, Stamatis Adamopoulos 25, Michael Bohm 26, Anna Norhammar 3, Andreas Bollmann 27, Amitava Banerjee 28, Aldo P Maggioni 29, Adriaan Voors 30, Alain Cohen Solal 31, Andrew J S Coats 32
Heart failure (HF) is a long-term clinical syndrome, with increasing prevalence and considerable healthcare costs that are further expected to increase dramatically.
Despite significant advances in therapy and prevention, mortality and morbidity remain high and quality of life poor. Epidemiological data, that is, prevalence, incidence, mortality, and morbidity, show geographical variations across the European countries, depending on differences in aetiology, clinical characteristics, and treatment. However, data on the prevalence of the disease are scarce, as are those on quality of life.
For these reasons, the ESC-HFA has developed a position paper to comprehensively assess our understanding of the burden of HF in Europe, in order to guide future policies for this syndrome. This manuscript will discuss the available epidemiological data on HF prevalence, outcomes, and human costs-in terms of quality of life-in European countries.
Keywords: Epidemiology; Heart failure; Impact; Morbidity; Mortality; Prognosis; Quality of life.